Author:
Banerjee Shubhasree,Biehl Ann,Gadina Massimo,Hasni Sarfaraz,Schwartz Daniella M.
Publisher
Springer Science and Business Media LLC
Reference203 articles.
1. O’Shea JJ, Kontzias A, Yamaoka K, et al. Janus kinase inhibitors in autoimmune diseases. Ann Rheum Dis. 2013;72(Suppl. 2):ii111–5. doi:
10.1136/annrheumdis-2012-202576
.
2. Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039. doi:
10.1038/nrdp.2016.39
.
3. Yamaoka K. Janus kinase inhibitors for rheumatoid arthritis. Current Opin Chem Biol. 2016;32:29–33. doi:
10.1016/j.cbpa.2016.03.006
.
4. Hodge JA, Kawabata TT, Krishnaswami S, et al. The mechanism of action of tofacitinib: an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(2):318–28.
5. Clark JD, Flanagan ME, Telliez JB. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases. J Med Chem. 2014;57(12):5023–38. doi:
10.1021/jm401490p
.
Cited by
813 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献